L. F. Boullosa

Most-cited papers

1. Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition

   C. Deben, L. F. Boullosa, Felicia Rodrigues Fortes, Edgar Cardenas De La Hoz +12 more

   2024Journal of experimental & clinical cancer research : CR21 citations Open access

   Semantic Scholar

   Save

2. Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia

   L. F. Boullosa, P. Savaliya, S. Bonney, L. Orchard +7 more

   2017OncoTarget14 citations Open access

   Semantic Scholar

   Save

3. Characterization of acquired nutlin-3 resistant non-small cell lung cancer cells

   C. Deben, L. F. Boullosa, A. Domen, A. Wouters +4 more

   2020Cancer Drug Resistance11 citations Open access

   Semantic Scholar

   Save

4. Abstract 2962: Molecular mechanisms underlying the sensitizing effect of mutant p53 protein expression for Auranofin treatment of NSCLC and PDAC cells

   L. F. Boullosa, F. Lardon, E. Smits, C. Deben

   2020Experimental and Molecular Therapeutics0 citations

   Semantic Scholar

   Save

5. Abstract 2414: Immunogenic properties of chemotherapeutic agents in the treatment of non-small cell lung cancer

   T. Flieswasser, J. Van Loenhout, L. F. Boullosa, Astrid Van Den Eynde +6 more

   2020Molecular and Cellular Biology / Genetics0 citations

   Semantic Scholar

   Save

6. PO-408 New targets for the immunotherapy of adult B-cell acute lymphocytic leukaemia

   L. F. Boullosa, L. Cooksey, P. Savaliya, S. Bonney +5 more

   2018ESMO Open0 citations Open access

   Semantic Scholar

   Save